Cleared Traditional

K213467 - EVA NEXUS Ophthalmic Surgical System (FDA 510(k) Clearance)

Jun 2022
Decision
229d
Days
Class 2
Risk

K213467 is an FDA 510(k) clearance for the EVA NEXUS Ophthalmic Surgical System. This device is classified as a Unit, Phacofragmentation (Class II - Special Controls, product code HQC).

Submitted by D.O.R.C. Dutch Ophthalmic Research Center (International) (Zuidland, NL). The FDA issued a Cleared decision on June 14, 2022, 229 days after receiving the submission on October 28, 2021.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.4670.

Submission Details

510(k) Number K213467 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2021
Decision Date June 14, 2022
Days to Decision 229 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code HQC - Unit, Phacofragmentation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.4670

Similar Devices - HQC Unit, Phacofragmentation

Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E)
K252052 · Bausch and Lomb, Incorporated · Mar 2026
UNITY VCS (8065000296)
K233876 · Alcon Laboratories, Inc. · Jun 2024
Centurion™ Vision System (Active Sentry™) (8065753057)
K233902 · Alcon Laboratories, Inc. · Jan 2024
QUATERA 700
K230858 · Carl Zeiss Meditec, AG · Jul 2023
QUATERA 700
K212241 · Carl Zeiss Meditec, AG · Apr 2022